← All companies
HALO annual revenue
HALOZYME THERAPEUTICS, INC.
HALO - CIK 0001159036
Market cap$8.36 B
Rank#1040
SEC filings1,481
HALOZYME THERAPEUTICS, INC. revenue by year
HALOZYME THERAPEUTICS, INC. (HALO) reported revenue of $1.40B for fiscal year 2025, as filed in its audited annual report with the SEC.
HALO revenue 2011-2025
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $1.40B | +37.6% |
| FY 2024 | $1.02B | +22.4% |
| FY 2023 | $829.25M | +25.6% |
| FY 2022 | $660.12M | +48.9% |
| FY 2021 | $443.31M | +65.7% |
| FY 2020 | $267.59M | +36.5% |
| FY 2019 | $195.99M | +29.1% |
| FY 2018 | $151.86M | -52.0% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does HALOZYME THERAPEUTICS, INC. make?
HALOZYME THERAPEUTICS, INC. (HALO) reported revenue of $1.40B for fiscal year 2025, as filed in its audited annual report with the SEC.
How has HALOZYME THERAPEUTICS, INC.'s revenue changed over time?
Between fiscal 2011 and fiscal 2025, HALOZYME THERAPEUTICS, INC.'s revenue grew from $56.09M to $1.40B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.